Related Experiment Videos
Vascular abnormalities in hypertension: cause, effect, or therapeutic target?
Gary E McVeigh1, Rick Plumb, Sinead Hughes
1Department of Therapeutics and Pharmacology, Queen's University Belfast, Whitla Medical Building, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland. g.mcveigh@qub.ac.uk
Current Hypertension Reports
|May 7, 2004
Summary
Hypertension damages organs through arterial changes. Restoring microvascular function, not just lowering blood pressure, is key and may depend on the specific antihypertensive drug used.
Area of Science:
- Cardiovascular Medicine
- Vascular Biology
- Hypertension Research
Background:
- Hypertension leads to end-organ damage via arterial alterations.
- Structural and functional changes in microcirculation are early signs of hypertension.
- Reversing these vascular abnormalities and restoring endothelial function is increasingly important.
Purpose of the Study:
- To highlight the significance of addressing structural and functional vascular changes in hypertension.
- To emphasize that microvascular function normalization may not solely rely on blood pressure reduction.
- To suggest that the choice of antihypertensive agent class influences microvascular recovery.
Main Methods:
- Review of existing literature on hypertension-related vascularpathology.
- Analysis of studies investigating microvascular function and endothelial function in hypertensive patients.
- Comparison of the effects of different antihypertensive drug classes on vascular structure and function.
Main Results:
- Microvascular alterations are a hallmark of early hypertension.
- Blood pressure reduction alone does not always restore normal microvascular function.
- The class of antihypertensive agent used can impact the degree of microvascular normalization.
Conclusions:
- Therapeutic strategies should aim to reverse pathogenic vascular abnormalities in hypertension.
- Restoring microvascular structure and endothelial function is a rational clinical goal.
- Further research is needed to confirm the clinical efficacy of targeting vascular abnormalities with specific drug classes.